Next Article in Journal
Impact of the Recipient’s Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation
Previous Article in Journal
Structural and Kinetic Characterization of the SpeG Spermidine/Spermine N-acetyltransferase from Methicillin-Resistant Staphylococcus aureus USA300
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 12
Issue 14
10.3390/cells12141830
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development

by
Jaroslav Kalous
1,*,
Daria Aleshkina
1,2 and
Martin Anger
1
1
Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 277 21 Libechov, Czech Republic
2
Department of Cell Biology, Faculty of Science, Charles University, Albertov 6, 128 00 Praha, Czech Republic
*
Author to whom correspondence should be addressed.
Cells 2023, 12(14), 1830; https://doi.org/10.3390/cells12141830
Submission received: 1 June 2023 / Revised: 24 June 2023 / Accepted: 6 July 2023 / Published: 12 July 2023
(This article belongs to the Special Issue Advances in Cellular and Molecular Regulation of Mammalian Meiosis and Other Model Organisms)
Browse Figures
Versions Notes

Abstract

:
A serine/threonine-specific protein kinase B (PKB), also known as Akt, is a key factor in the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway that regulates cell survival, metabolism and proliferation. Akt phosphorylates many downstream specific substrates, which subsequently control the nuclear envelope breakdown (NEBD), centrosome maturation, spindle assembly, chromosome segregation, and cytokinesis. In vertebrates, Akt is also an important player during oogenesis and preimplantation development. In the signaling pathways regulating mRNA translation, Akt is involved in the control of mammalian target of rapamycin complex 1 (mTORC1) and thereby regulates the activity of a translational repressor, the eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1). In this review, we summarize the functions of Akt in mitosis, meiosis and early embryonic development. Additionally, the role of Akt in the regulation of mRNA translation is addressed with respect to the significance of this process during early development.

1. Introduction

Female germ cells and developing embryos are unique in many aspects, including their life cycle, cell cycle regulation and transcriptional silencing. In mammals, the primordial germ cells appear early during embryonic development. After migration to the gonadal ridges, which will eventually develop into gonads, cells increase their numbers by undergoing multiple mitotic divisions. Then, after entering meiosis while still in utero, they become arrested in the prophase of the first meiotic division until puberty, after which they are gradually recruited for further development. The key step, essential for oocyte development, is an interaction with cells of mesodermal origin within the developing gonads, which will lead into formation of the follicles. After puberty, when the follicle-stimulating hormone (FSH)/luteinizing hormone (LH) surges gradually stimulate their further development, primordial follicles, together with oocytes they surround, are recruited for growth. During this period, oocytes dramatically increase their size and eventually acquire competence to resume meiosis, after which they undergo two consecutive chromosomal divisions, without DNA replication in between, resulting in haploid cells, which are ready for fertilization. Coincidentally with reaching their full size, oocytes become transcriptionally inactive [1]. The completion of meiosis, fertilization and early embryonic development are therefore dependent on regulated translation of maternally synthetized mRNAs, accumulated during oocyte growth [2,3]. Although the maternal RNAs are highly stable in germinal vesicle (GV) stage oocytes, over 90% of these mRNAs are degraded soon after fertilization during the first mitotic divisions [4] and the future of the embryo depends on successful activation of its genome. Considering the unique life cycle of oocytes and also transcription independent control of meiosis, fertilization and early cleavage cycles of developing embryos, it is clear that pathways involved in translation and cell cycle control, including the phosphoinositide-3-kinase (PI3K)/Akt signaling pathway, are of paramount importance [5].

2. The Protein Kinase Akt

The serine/threonine protein kinase Akt (v-akt murine thymoma viral oncogene homolog) is a component of the phosphoinositide 3-kinase (PI3K)/Akt signaling cascade that plays a critical role in a variety of cellular processes, including cell cycle progression, glucose metabolism, transcription, cellular growth, embryogenesis, as well as angiogenesis [6,7,8]. The Akt kinase family is comprised of three highly homologous isoforms: Akt1, Akt2 and Akt3, which are closely related and consist of a conserved N-terminal pleckstrin homology (PH) domain, a central catalytic domain, and a C-terminal regulatory hydrophobic motif (HM) [9]. The expression of Akt isoforms is tissue-dependent; whereas the Akt1 and Akt2 are expressed in multiple tissues, the expression of Akt3 is mainly restricted to the brain [10]. The activation of Akt is initiated by its recruitment to the plasma membrane through the binding of the PH domain of Akt to the phosphatidylinositol-3,4,5-trisphosphate (PIP3). Subsequently, it requires phosphorylation by the PI3K-dependent kinase 1 (PDK1) at the threonine 308 (Thr308) residue within the activation T-loop of the catalytic domain and at serine 473 (Ser473) residue within the carboxyl terminal hydrophobic domain. The phosphorylation at Ser473 is performed by the mammalian target of rapamycin complex 2 (mTORC2) [11,12]. Akt becomes fully activated only when it is phosphorylated at both the Thr308 and Ser473 residues [13].
Activated Akt dissociates from the plasma membrane and it is translocated to both the cytosol and nucleus, where many of its substrates are located [14,15]. The downstream effect of Akt activity is mediated through the serine and/or threonine phosphorylation of specific substrates involved in a range of cellular and physiological processes [16,17].
Inactivation of the PI3K/Akt pathway is mainly accomplished by phosphatase and tensin homologue deleted on chromosome 10 (PTEN), which exhibits dual lipid and protein phosphatase activity [18]. PTEN specifically catalyzes dephosphorylation of the 3′ phosphate of the inositol ring in phospholipid PIP3, resulting in formation of the bisphosphate product phospholipid PIP and inhibition of Akt activity [19]. On the other hand, Akt is also inactivated directly by dephosphorylation of the pT308 residue by protein phosphatase 2A (PP2A), dephosphorylation of the pSer473 residue is accomplished by the PH domain leucine-rich repeat protein phosphatases (PHLPP) [20,21].

3. Role of Akt in Cell Cycle Control

3.1. Akt Is Involved in Regulation of Mitosis

The PI3K/Akt signaling pathway is involved in the control of cell cycle progression as well as of cell proliferation and survival [22]. Akt regulates multiple processes and pathways in each cell cycle stage. One of the best known examples is the activation of cyclin-dependent kinases (CDKs), the serine threonine kinases that play principal roles in the control of cell division [23,24,25]. During the G1 phase, Akt/mTOR has stimulatory effect on cell cycle progression by promoting the expression of cyclin D1, cyclin-dependent kinase 4 (CDK4) and phosphatase CDC25A [26]. At the G1/S transition, Akt promotes the phosphorylation and inactivation of p21WAF1 and p27kip1, the inhibitors of cyclin-dependent kinase 2 (CDK2) [27,28] (Table 1).
A significantly higher Akt activity suggests a specific role of this kinase during the transition from S to G2 phase [29,33]. The activation of CDK1, a catalytic subunit of the M phase-promoting factor (MPF), is essential for cell cycle progression through the S/G2 and G2/M phase in both meiosis and mitosis [34,35]. In the G2/M phase, Akt regulates the cell cycle progression through the direct phosphorylation of CDK1 activators and inhibitors, demonstrating the important role of PI3K/AKT pathway in promoting cell division [23,24]. Specifically, CDK1 at this point is inhibited by Wee1 and Myt1 kinases, which phosphorylate Thr14 and Tyr15 residues within CDK1 ATP binding pocket and when cells are ready for G2/M transition, Akt by phosphorylation inhibits both Wee1 and Myt1 kinases [36]. Akt also phosphorylates and activates the CDC25 phosphatase, which is important for removal of CDK1 Thr14 and Tyr15 phosphorylation, previously facilitated by Wee1 and Myt1, enabling the activation of CDK1 during the G2/M transition [24]. Akt is involved in the control of the mitotic spindle checkpoint [30], localizes to the spindle poles [37], affects the integrity and composition of mitotic centrosomes [31], and participates on the regulation of cytokinesis [32].

3.2. Akt Affects Progression of Meiosis

In the developing ovary, Akt promotes the proliferation of primordial germ cells [38]. After entering meiosis, mammalian oocytes are arrested in the prophase of the first meiotic division until resumption of meiosis. During the in vitro maturation (IVM) of mammalian cumulus-oocyte complexes (COCs), Akt is present in both oocytes and cumulus cells (CCs), and its activity is required for the regulation of meiotic progression [39,40,41] (Table 2).
In the fully grown oocytes residing in the antral ovarian follicles, the Akt activity is at very low level [39,40]. In some species, its activity is however required during resumption of meiosis. In mouse oocytes for example, the phosphorylation of Akt by the upstream kinases is necessary to promote the resumption of meiosis under both in vivo and in vitro conditions [42,43,44]. Similarly to the somatic cells, in oocytes Akt has been reported to be involved in CDK1 activation and induction of germinal vesicle breakdown (GVBD); equivalent to nuclear envelope breakdown or NEBD in somatic cells. For its full activity during GVBD, Akt requires the phosphorylation of both T308 and S473 residues [43]. This crucial role of Akt in CDK1 activation and GVBD induction was also reported in starfish and zebrafish oocytes [45,46,52]. In contrast to the mouse and starfish, the Akt activity seems to be dispensable during GVBD in porcine oocytes. Another meiotic event, during which the Akt activity is required, is the transition from meiosis I to meiosis II. The role of Akt during this process seems to be generally conserved, as it was shown in bovine [39,47], mouse [43,48] Xenopus [49] and porcine oocytes [40] (Table 2; Figure 1).
Spindle assembly during meiosis is unique. In contrast to mitosis in somatic cells, and also to sperm meiosis, in which the spindle assembly is driven by centrosomes, in oocytes the assembly of the spindle in both meiotic divisions is acentrosomal and requires instead the clustering of microtubule-organizing centers (MTOCs) [53,54,55]. The centrosomes are lost during oocyte development [56] and this fundamental difference between spindle assembly in somatic cells and oocytes might contribute to the higher incidence of chromosome segregation errors in the latter. The localization pattern on meiotic spindle indicates an important role of Akt in the assembly and stabilization of this structure [43,48,50]. During oocyte meiosis, Akt becomes phosphorylated at either Ser473 (pS473-Akt) or Thr308 (pT308-Akt) residues, which has consequences for the diversity of Akt functions. It also affects the localization pattern on meiotic spindle. Whereas pT308-Akt localization is restricted to the spindle poles, pS473-Akt is detected along the spindle microtubules [43,48,50]. And for correct spindle assembly in meiosis II, Akt carrying simultaneously phosphorylation of both Ser473 and Thr308 residues, is required [48].
In addition, Akt is an important player in the regulation of apoptosis, in somatic cells Akt prevents the translocation of the BAX protein to the mitochondria to start apoptosis [57]. Akt is also involved in the control of apoptosis during meiosis, the elevation of Akt activity in matured oocytes led to an enhanced expression of genes involved in cell signaling and proliferation, and to a decreased expressions of pro-apoptotic genes such as BAX, BCL2 and caspase-3 [58]. It has been suggested that Akt could be involved in the regulation of the expression, activity and localization of pro-apoptotic proteins in oocytes and, moreover, AKT could stabilize endogenous apoptosis inhibitors [59].
Overall, Akt plays a critical role in regulating various aspects of meiosis, including entry into meiosis, progression through the MI to MII stage, and apoptosis. The dysregulation of Akt activity during oocyte maturation can lead to defects in meiosis and can result in infertility or birth defects.

4. Role of Akt in Oogenesis and Folliculogenesis

4.1. Akt Regulates Follicle Development

The Akt signaling pathway is an important regulator of ovarian functions, such as the survival, proliferation, and differentiation of granulosa cells (GCs) [60]. Akt also regulates quiescence and the activation of primordial follicles [61]. The development of ovarian follicles begins with the proliferation of GCs, which are the predominant somatic cell type of the ovarian follicle and are involved in steroidogenesis and folliculogenesis [62]. During the growth and development of the ovarian follicle, the undifferentiated GCs are present from primordial to preantral follicles [63]. In antral follicles, GCs differentiate into CCs and mural granulosa cells (MGCs), CCs surround the oocyte and MGCs form a layer that is firmly attached to the inner wall of the follicle. During folliculogenesis in the human ovary, Akt has been detected in oocytes, in MGCs and in the thecal cells of primordial follicles, in growing follicles, and in the luteal cells [64]. The results on mouse knock-out models revealed the importance of Akt in oocyte growth and in the expression of cell-cycle regulators. The fertility of Akt1−/− female mice was reduced due to the altered follicular development and abnormal oocyte growth [65]. In the Akt1−/− ovaries, there was a reduced expression of cell-cycle regulators cyclin D1 and cyclin D3, and the expression of the survival factor KIT ligand and anti-apoptotic factor BCL2 like 1 was also decreased [65]. In the cultured ovine preantral follicles, activation of the PI3K/AKT pathway led to a promotion of primordial follicle activation and cell proliferation, and resulted in a reduction of DNA fragmentation [66].

4.2. Akt Promotes Survival of GCs

MGCs, which form an inner layer of the ovarian follicle, play a crucial role in the development of oocytes as they produce factors essential for oocyte growth and folliculogenesis [67]. The activity of the PI3K/Akt pathway is necessary for the induction of numerous critical genes that mark the fully differentiated preovulatory MGCs [68,69]. The PI3K/Akt pathway in in vitro cultured GCs can be activated by insulin-like growth factor 1 (IGF1) via the type-I IGF receptor (IGF1R), indicating that the IGF1-regulation of the PI3K/Akt pathway activity plays role in the control of cell cycle progression as well as in the promotion of GCs survival [70,71]. The IGF1-activated PI3K/Akt pathway protects GCs from apoptosis, and this protective effect can only occur when progression from the G1 to S phase of the cell cycle, regulated by the PI3K/Akt pathway, is not disrupted [72]. Mechanisms leading to the regulation of Akt phosphorylation induce changes in the proliferation and differentiation of MGCs cells during the growth of ovarian follicles [64]. The promoting effect of the PI3K/Akt signaling pathway activity on cell survival within the granulosa layer is important for the development of the preovulatory ovarian follicle [73].

4.3. Activity of Akt in CCs

In mammals, CCs surrounding the oocyte play an important role in oocyte growth, meiotic maturation, ovulation and fertilization [74]. The inner layer of CCs known as the corona radiata, and the oocyte together with the surrounding CCs form the COC [75]. The activity of the PI3k/Akt pathway in CCs has at least two important roles during the meiotic maturation of oocytes [76]. Firstly, the low level of Akt activity in CCs is essential for the establishment of meiotic arrest. And secondly, Akt activation in CCs is linked to the induction of gonadotropin-stimulated meiotic resumption.
CCs regulate oocyte development and meiotic maturation by generating paracrine factors and, moreover, CCs control the resumption of meiosis and formation of the oocyte cytoskeleton [77]. Activated PI3K/Akt in CCs ensures the transduction of pro-survival signals essential for oocyte development [63]. Specific CCs genes strictly associated with the oocyte developmental competence are regulated by the PI3K/Akt pathway [78].

4.4. Akt Regulates Signaling between CCs and Oocytes

In developing mammalian follicles, CCs transport nutrients such as amino acids and substrates for energy production to the oocytes via cytoplasmic processes known as transzonal projections (TZPs), which originate from CCs and penetrate the zona pellucida, the outer layer of the oocyte [79,80,81]. Terminally, TZPs form heterologous gap junctions with cytoplasmic membrane of oocyte. Gap junctions are intercellular channels that permit the direct transfer of ions and small molecules (<1 kDa) between adjacent cells [82]. The close relationship of oocytes and CCs is crucial for the regulation of oocyte growth and development. The bidirectional communication between the oocyte and CCs via heterologous gap junctions is essential for the formation of a developmentally competent oocyte, which can be fertilized, and which is also able to support subsequent embryonic development [83]. The PI3K/Akt pathway plays an essential role in the communication between the developing oocyte and CCs [84]. Gap junction channels are composed of connexins (Cx), and Cx proteins enable the communication between the oocyte and accompanying CCs [85]. In somatic cells, Akt mediates the phosphorylation of Cx43 in gap junctions itself [86]. In COCs, the activity of the PI3K/Akt signaling pathway is closely associated with the progression of meiosis via the regulation of CX43 phosphorylation in CCs [87,88].

4.5. Role of Akt in Expansion of CCs

The PI3K/Akt pathway not only promotes the nuclear maturation of oocytes, but also supports expansion of the oocyte cumulus layer, a process that is important for the maturation and fertilization of oocytes [75]. In response to LH surge, CCs surrounding the oocyte synthesize a large amount of high molecular weight glycosaminoglycan hyaluronan (HA), a major component of the extracellular matrix (ECM) that plays multiple roles during and after fertilization [89]. The cross linking of HA with tumor necrosis alpha-induced protein 6 (TNFAIP6), inter-alpha-trypsin inhibitors (IαI), and pentraxin 3 (PTX3) is a pre-requisite for the appropriate formation of ECM, essential for oocyte ovulation and fertilization [89,90,91]. HA synthesis in the FSH-stimulated COCs and retention of HA in the cumulus ECM are PI3K/Akt dependent [92]. Inhibition of the PI3K/Akt pathway dramatically reduced the expression levels of hyaluronan synthase 2 (HAS2) and TNFAIP6, the key enzymes involved in the production and stabilization of HA in the expanding cumulus, indicating that the activity of Akt is essential for the expression of genes involved in the expansion of the oocyte cumulus [93,94]. It has been proposed that activation of a downstream Akt effector, the mammalian target of rapamycin (mTOR), in the oocyte cumulus cells is essential for the production of functionally competent matured oocytes [95].

5. The Role of Akt in mRNA Translation

5.1. Akt Regulates mTOR Activity during Mitosis

One of the key downstream targets of Akt is the mTOR pathway, which plays a critical role in the regulation of mRNA translation, and the link between the PI3K/AKT and mTOR pathway is essential for oocyte meiotic maturation [61]. The mTOR pathway is activated by a variety of signals, including growth factors, nutrients, and energy status. MTOR, a serine-threonine kinase, is a component of mTOR complex 1 (mTORC1) and mTORC2, two cellular complexes that have distinct functions and regulation [96,97]. MTORC1 controls the translation of several proteins that are important for growth and cell cycle progression [98,99]. Akt directly phosphorylates and activates mTORC1, which in turn stimulates the phosphorylation of key downstream targets, including the mTORC1 effectors p70 ribosomal protein S6 kinase (p70S6K), which phosphorylates the eukaryotic translation initiation factor 4B (eIF4B) and is essential for the translation of 40s ribosomal S6 protein, and 4E-BP1, which regulates cell proliferation via the control of the cap-dependent translation and acts as a translational repressor [100,101,102]. The phosphorylation of p70S6K and 4E-BP1 mediates the transduction of mitogen and nutrient signals to stimulate translation [103].
Akt-activated mTORC1 pathway promotes the translation of mRNAs involved in cell cycle progression, such as cyclins and CDKs [61]. Hypophosphorylated 4E-BP1 prevents eIF4E from associating with eIF4G. Upon phosphorylation by Akt and mTORC1, 4E-BP1 dissociates from eIF4E, and this event enables assembly of the eIF4F complex [104,105]. The deregulation of protein synthesis downstream of mTORC1 at the level of 4E-BP1/eIF4E plays a central role in tumor formation, and 4E-BP1/eIF4E transfers the effect of oncogenic Akt signaling on mRNA translation, cell growth, and tumor progression [106]. Akt directly activates mTORC1 by phosphorylating the proline-rich Akt substrate 40 kDa (PRAS40), a protein that associates with mTORC1 and regulates mTORC1 kinase activity by the direct inhibition of substrate binding [107,108]. Akt also activates mTORC1 indirectly by phosphorylating and inactivating two tumor suppressor proteins, tuberous sclerosis complex 1 (TSC1), also known as tuberin, and tuberous sclerosis complex 2 (TCS2), also known as hamartin [109,110]. TSC2 has a role as a GTPase-activating protein (GAP) which inactivates an essential mTORC1 activator, the RAS homologue enriched in the brain (Rheb) [111]. TSC1 and TSC2 form a functional complex that acts as a key upstream negative regulator of mTORC1 kinase activity and exerts its effects through mTORC1 to regulate the activity of p70S6K and 4E-BP1 [110] (Figure 2).
Additionally, Akt can indirectly regulate mRNA translation by affecting the activity of other translation factors, such as eukaryotic initiation factor 2B (eIF2B) and eukaryotic elongation factor 2 (eEF2), which are involved in the initiation and elongation phases of mRNA translation, respectively [112,113].

5.2. Akt Affects mTORC1 Activity during Oocyte Meiosis

MTORC1 is expressed in all stages of oocytes development, suggesting its fundamental role in regulation of oocyte meiosis and early embryonic development [114]. In oocytes, mTORC1 acts as a downstream Akt effector, and mTORC1 activation in CCs is essential for the production of functionally competent mature oocytes [95].
In mammalian oocytes, the temporal and spatial control of translation is regulated via an mTORC1-eIF4F pathway [115]. The incorporation of eIF4E into the pathway required for the initiation of translation is regulated by its phosphorylation in oocytes as well as through binding of inhibitory proteins [116]. In GV stage oocytes, mTORC1 is localized to the cytoplasm, at GVBD it is distributed around chromosomes, and at M-phase it is localized on the meiotic spindles in the vicinity of the chromosomes [117]. During meiotic maturation of mouse oocytes phosphorylated Akt localizes to meiotic spindle, and this localization overlaps with mTORC1 localization [43,48]. It is tempting to speculate that Akt regulates a localized translation of specific mRNAs, necessary for spindle assembly, via co-localization with mTORC1 on the spindle (Figure 3).
Although phosphorylated Akt is an upstream activator of mTORC1 in somatic cells, it has been suggested that during the meiosis of mammalian oocytes, the Akt pathway is not sufficient for full mTORC1 activation, which is likely to be mediated by CDK1 instead [118]. However, downregulation of the AKT/mTORC1 pathway and its downstream signaling cascades during IVM reduces the quality and developmental potential of porcine and bovine oocytes [58,119]. In MII oocytes, phosphorylated Akt is localized to the MII spindle along with ribosomal protein S6 (RPS6) and 4E-BP1 [48,118]. This suggests that Akt, localized to the MII spindle, regulates the activity of the mTORC1 pathway components.

6. Akt in Zygotic Transition and Early Embryo Development

After fertilization, the PI3K/AKT pathway becomes activated by autocrine trophic ligands, and the activity of this pathway is essential for early embryo development [120,121]. In the 2-cell mouse embryo, active mTORC1 is required for 4E-BP1 phosphorylation and eIF4E activation, a prerequisite for the initiation of mRNA translation [122]. The maternally provided eIF4E is able to support mouse embryo up to the two- to four-cell stage, after which a newly expressed eIF4E from the embryonic genome is required, marking the important switch from maternal to embryonic control of translation during development [122].
MTORC1 is activated under favorable conditions such as the availability of amino acids (AAs), growth factors, and intracellular ATP. The importance of the mTORC1 pathway for promoting normal preimplantation development can be demonstrated on embryos cultured in vitro. Although in mouse the simple culture media without amino acids are able to support embryo development to the blastocyst stage, the preimplantation embryo viability and developmental potential could be improved by supplementing the culture media with essential and nonessential amino acids [123,124]. In the bovine and human embryos cultured in the absence of AAs, the phosphorylation of Akt on Ser473 is decreased, together with declined of mTORC1 signaling, resulting in compromised preimplantation development, partially restorable by addition of AAs [125]. The PI3K/Akt signaling pathway is also important for the normal development of the early embryo to the blastocyst stage [126] (Table 3).
In the early drosophila embryos, Akt regulates centrosome migration, mitotic spindle orientation, and promotes proper spindle morphology [133]. In zygote, pSer473-Akt localizes to both male and female pronuclei and similarly to somatic cells plays important role during the mitotic entry [127,128]. In 2-cell embryos, the pSer473-Akt also shows nuclear localization [129]. The nuclear localization of pSer473-Akt during major zygotic genome activation (ZGA), and the 2-cell embryos arrest induced by the specific Akt inhibition indicate that Akt is possibly involved in the major ZGA in 2-cell mouse embryos [130]. Moreover, the inhibition of Akt compromised the development of mouse embryos to the blastocyst stage, suggesting that Akt activity has a significant effect on normal blastocyst development [120,132]. It has been proposed that the regulation of blastomere proliferation in preimplantation mouse embryos is based on Akt activity [128]. Activated Akt is essential for mouse blastocyst formation and for expression of the trophectoderm marker Cdx2, indicating that Akt may be indispensable for the first cell lineage differentiation in the mouse early embryo [134]. The importance of Akt signaling for the developmental competence of the early embryo was revealed by Akt inhibition that resulted in a reduction of early embryo cleavage and compromised embryo development to the 8- to 16-cell and blastocyst stages [131]. The data from Xenopus and starfish early embryos suggest that Akt is involved in the regulation of the mitotic G2 to M phase transition through the activation of M-phase promoting factor (MPF) [36,46]. In summary, Akt plays a critical role in regulating mRNA translation, embryonic development, and cell survival during the early stages of embryogenesis.

7. Conclusions

Akt plays an important role in regulating various aspects of cell cycle, it is involved in the control of key points in meiosis and mitosis. In oocytes, Akt supports the entry into meiosis and transition from meiosis I to meiosis II. Akt is also essential for embryonic development after fertilization. Dysregulation of Akt activity during the meiotic maturation of oocytes can lead to defects in meiosis and impair preimplantation development resulting in infertility or birth defects. The summarized data indicate that the gene expression and activity of the PI3K/AKT pathway can be possibly used as a predictive marker for the developmental competence of oocytes and successful embryo implantation. Detailed identification of PI3K/Akt/mTOR downstream factors that promote developmental competence of oocytes could be of importance for assisted reproduction.

Author Contributions

Writing—original draft preparation, editing, J.K.; editing, figures design, D.A.; writing, editing, M.A. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the grant CZ.02.1.01/0.0/0.0/15_003/0000460 from the Operational Programme Research, Development, and Education; by Institutional Research Concept RVO67985904; by GAUK 389321 for D.A. and by GACR (22-27301S).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tanaka, M.; Kihara, M.; Hennebold, J.D.; Eppig, J.J.; Viveiros, M.M.; Emery, B.R.; Carrell, D.T.; Kirkman, N.J.; Meczekalski, B.; Zhou, J.; et al. H1FOO Is Coupled to the Initiation of Oocytic Growth. Biol. Reprod. 2005, 72, 135–142. [Google Scholar] [CrossRef] [PubMed]
  2. Alizadeh, Z.; Kageyama, S.-I.; Aoki, F. Degradation of maternal mRNA in mouse embryos: Selective degradation of specific mRNAs after fertilization. Mol. Reprod. Dev. 2005, 72, 281–290. [Google Scholar] [CrossRef] [PubMed]
  3. Richter, J.D.; Lasko, P. Translational Control in Oocyte Development. Cold Spring Harb. Perspect. Biol. 2011, 3, a002758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Bianchi, E.; Sette, C. Post-Transcriptional Control of Gene Expression in Mouse Early Embryo Development: A View from the Tip of the Iceberg. Genes 2011, 2, 345–359. [Google Scholar] [CrossRef]
  5. Manning, B.D.; Cantley, L.C. AKT/PKB Signaling: Navigating Downstream. Cell 2007, 129, 1261–1274. [Google Scholar] [CrossRef] [Green Version]
  6. Topisirovic, I.; Sonenberg, N. mRNA translation and energy metabolism in cancer: The role of the MAPK and mTORC1 pathways. Cold Spring Harb. Symp. Quant. Biol. 2011, 76, 355–367. [Google Scholar] [CrossRef]
  7. Kandel, E.S.; Skeen, J.; Majewski, N.; Di Cristofano, A.; Pandolfi, P.P.; Feliciano, C.S.; Gartel, A.; Hay, N. Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage. Mol. Cell. Biol. 2002, 22, 7831–7841. [Google Scholar] [CrossRef] [Green Version]
  8. Nogueira, V.; Hay, N. Molecular pathways: Reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 2013, 19, 4309–4314. [Google Scholar] [CrossRef] [Green Version]
  9. Hanada, M.; Feng, J.; Hemmings, B.A. Structure, regulation and function of PKB/AKT—A major therapeutic target. Biochim. Biophys. Acta-Proteins Proteom. 2004, 1697, 3–16. [Google Scholar] [CrossRef]
  10. Hollander, M.C.; Maier, C.R.; Hobbs, E.A.; Ashmore, A.R.; Linnoila, R.I.; Dennis, P.A. Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene 2011, 30, 1812–1821. [Google Scholar] [CrossRef] [Green Version]
  11. Manning, B.D.; Toker, A. AKT/PKB Signaling: Navigating the Network. Cell 2017, 169, 381–405. [Google Scholar] [CrossRef] [Green Version]
  12. Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 1998, 10, 262–267. [Google Scholar] [CrossRef]
  13. Woodgett, J.R. Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 2005, 17, 150–157. [Google Scholar] [CrossRef]
  14. Ebner, M.; Lučić, I.; Leonard, T.A.; Yudushkin, I. PI(3,4,5)P3 Engagement Restricts Akt Activity to Cellular Membranes. Mol. Cell 2017, 65, 416–431.e6. [Google Scholar] [CrossRef] [Green Version]
  15. Calleja, V.; Alcor, D.; Laguerre, M.; Park, J.; Vojnovic, B.; Hemmings, B.A.; Downward, J.; Parker, P.J.; Larijani, B. Intramolecular and Intermolecular Interactions of Protein Kinase B Define Its Activation In Vivo. PLoS Biol. 2007, 5, e95. [Google Scholar] [CrossRef] [Green Version]
  16. Hers, I.; Vincent, E.E.; Tavaré, J.M. Akt signalling in health and disease. Cell. Signal. 2011, 23, 1515–1527. [Google Scholar] [CrossRef]
  17. Lietzke, S.E.; Bose, S.; Cronin, T.; Klarlund, J.; Chawla, A.; Czech, M.P.; Lambright, D.G. Structural Basis of 3-Phosphoinositide Recognition by Pleckstrin Homology Domains. Mol. Cell 2000, 6, 385–394. [Google Scholar] [CrossRef]
  18. Bu, L.; Wang, H.; Pan, J.; Chen, L.; Xing, F.; Wu, J.; Li, S.; Guo, D. PTEN suppresses tumorigenesis by directly dephosphorylating Akt. Signal Transduct. Target. Ther. 2021, 6, 262. [Google Scholar] [CrossRef]
  19. Maehama, T.; Dixon, J.E. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate. J. Biol. Chem. 1998, 273, 13375–13378. [Google Scholar] [CrossRef] [Green Version]
  20. Gao, T.; Furnari, F.; Newton, A.C. PHLPP: A Phosphatase that Directly Dephosphorylates Akt, Promotes Apoptosis, and Suppresses Tumor Growth. Mol. Cell 2005, 18, 13–24. [Google Scholar] [CrossRef]
  21. Brognard, J.; Sierecki, E.; Gao, T.; Newton, A.C. PHLPP and a Second Isoform, PHLPP2, Differentially Attenuate the Amplitude of Akt Signaling by Regulating Distinct Akt Isoforms. Mol. Cell 2007, 25, 917–931. [Google Scholar] [CrossRef] [PubMed]
  22. Martelli, A.M.; Tabellini, G.; Bressanin, D.; Ognibene, A.; Goto, K.; Cocco, L.; Evangelisti, C. The emerging multiple roles of nuclear Akt. Biochim. Biophys. Acta-Mol. Cell Res. 2012, 1823, 2168–2178. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Cheung, M.; Testa, J.R. Diverse Mechanisms of AKT Pathway Activation in Human Malignancy. Curr. Cancer Drug Targets 2013, 13, 234–244. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Baldin, V.; Theis-Febvre, N.; Benne, C.; Froment, C.; Cazales, M.; Burlet-Schiltz, O.; Ducommun, B. PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation. Biol. Cell 2003, 95, 547–554. [Google Scholar] [CrossRef]
  25. Ornelas, I.M.; Silva, T.M.; Fragel-Madeira, L.; Ventura, A.L.M. Inhibition of PI3K/Akt Pathway Impairs G2/M Transition of Cell Cycle in Late Developing Progenitors of the Avian Embryo Retina. PLoS ONE 2013, 8, e53517. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Gao, N.; Flynn, D.C.; Zhang, Z.; Zhong, X.-S.; Walker, V.; Liu, K.J.; Shi, X.; Jiang, B.-H. G1 cell cycle progression and the expression of G 1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am. J. Physiol. Cell Physiol. 2004, 287, C281–C291. [Google Scholar] [CrossRef]
  27. Liang, J.; Slingerland, J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003, 2, 339–345. [Google Scholar] [CrossRef] [Green Version]
  28. Maddika, S.; Ande, S.R.; Wiechec, E.; Hansen, L.L.; Wesselborg, S.; Los, M. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J. Cell Sci. 2008, 121, 979–988. [Google Scholar] [CrossRef] [Green Version]
  29. Stern, A.D.; Smith, G.R.; Santos, L.C.; Sarmah, D.; Zhang, X.; Lu, X.; Iuricich, F.; Pandey, G.; Iyengar, R.; Birtwistle, M.R. Relating individual cell division events to single-cell ERK and Akt activity time courses. Sci. Rep. 2022, 12, 18077. [Google Scholar] [CrossRef]
  30. Rashid, M.S.; Mazur, T.; Ji, W.; Liu, S.T.; Taylor, W.R. Analysis of the role of GSK3 in the mitotic checkpoint. Sci. Rep. 2018, 8, 14259. [Google Scholar] [CrossRef] [Green Version]
  31. Leonard, M.; Hill, N.; Bubulya, P.; Kadakia, M. The PTEN-Akt pathway impacts the integrity and composition of mitotic centrosomes. Cell Cycle 2013, 12, 1406–1415. [Google Scholar] [CrossRef]
  32. Takegahara, N.; Kim, H.; Mizuno, H.; Sakaue-Sawano, A.; Miyawaki, A.; Tomura, M.; Kanagawa, O.; Ishii, M.; Choi, Y. Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts. J. Biol. Chem. 2016, 291, 3439–3454. [Google Scholar] [CrossRef] [Green Version]
  33. Maryu, G.; Matsuda, M.; Aoki, K. Multiplexed Fluorescence Imaging of ERK and Akt Activities and Cell-cycle Progression. Cell Struct. Funct. 2016, 41, 81–92. [Google Scholar] [CrossRef] [Green Version]
  34. Adhikari, D.; Zheng, W.; Shen, Y.; Gorre, N.; Ning, Y.; Halet, G.; Kaldis, P.; Liu, K. Cdk1, but not Cdk2, is the sole Cdk that is essential and sufficient to drive resumption of meiosis in mouse oocytes. Hum. Mol. Genet. 2012, 21, 2476–2484. [Google Scholar] [CrossRef] [Green Version]
  35. Diril, M.K.; Ratnacaram, C.K.; Padmakumar, V.C.; Du, T.; Wasser, M.; Coppola, V.; Tessarollo, L.; Kaldis, P. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc. Natl. Acad. Sci. USA 2012, 109, 3826–3831. [Google Scholar] [CrossRef]
  36. Katayama, K.; Fujita, N.; Tsuruo, T. Akt/Protein Kinase B-Dependent Phosphorylation and Inactivation of WEE1Hu Promote Cell Cycle Progression at G2/M Transition. Mol. Cell. Biol. 2005, 25, 5725–5737. [Google Scholar] [CrossRef] [Green Version]
  37. Wakefield, J.G.; Stephens, D.J.; Tavaré, J.M. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J. Cell Sci. 2003, 116, 637–646. [Google Scholar] [CrossRef] [Green Version]
  38. Kimura, T.; Tomooka, M.; Yamano, N.; Murayama, K.; Matoba, S.; Umehara, H.; Kanai, Y.; Nakano, T. AKT signaling promotes derivation of embryonic germ cells from primordial germ cells. Development 2008, 135, 869–879. [Google Scholar] [CrossRef] [Green Version]
  39. Tomek, W.; Smiljakovic, T. Activation of Akt (protein kinase B) stimulates metaphase I to metaphase II transition in bovine oocytes. Reproduction 2005, 130, 423–430. [Google Scholar] [CrossRef] [Green Version]
  40. Kalous, J.; Kubelka, M.; Šolc, P.; Šušor, A.; Motlík, J. AKT (protein kinase B) is implicated in meiotic maturation of porcine oocytes. Reproduction 2009, 138, 645–654. [Google Scholar] [CrossRef] [Green Version]
  41. Reddy, P.; Adhikari, D.; Zheng, W.; Liang, S.; Hämäläinen, T.; Tohonen, V.; Ogawa, W.; Noda, T.; Volarevic, S.; Huhtaniemi, I.; et al. PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles. Hum. Mol. Genet. 2009, 18, 2813–2824. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Han, S.J.; Vaccari, S.; Nedachi, T.; Andersen, C.B.; Kovacina, K.S.; Roth, R.A.; Conti, M. Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation. EMBO J. 2006, 25, 5716–5725. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Kalous, J.; Solc, P.; Baran, V.; Kubelka, M.; Schultz, R.M.; Motlik, J. PKB/AKT is involved in resumption of meiosis in mouse oocytes. Biol. Cell 2006, 98, 111–123. [Google Scholar] [CrossRef] [PubMed]
  44. Newhall, K.J.; Criniti, A.R.; Cheah, C.S.; Smith, K.C.; Kafer, K.E.; Burkart, A.D.; McKnight, G.S. Dynamic Anchoring of PKA Is Essential during Oocyte Maturation. Curr. Biol. 2006, 16, 321–327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Hiraoka, D.; Aono, R.; Hanada, S.; Okumura, E.; Kishimoto, T. Two novel competing pathways establish the threshold for cyclin B-Cdk1 activation at the meiotic G2/M transition. J. Cell Sci. 2016, 129, 3153–3166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Okumura, E.; Fukuhara, T.; Yoshida, H.; Hanada, S.; Kozutsumi, R.; Mori, M.; Tachibana, K.; Kishimoto, T. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat. Cell Biol. 2002, 4, 111–116. [Google Scholar] [CrossRef]
  47. Alcaráz, L.P.; Prellwitz, L.; Alves, G.; Souza-Fabjan, J.M.G.; Dias, A.J.B. Role of phosphoinositide 3-kinase/ protein kinase B/ phosphatase and tensin homologue (PI3K/AKT/PTEN) pathway inhibitors during in vitro maturation of mammalian oocytes on in vitro embryo production: A systematic review. Theriogenology 2022, 189, 42–52. [Google Scholar] [CrossRef]
  48. Hoshino, Y.; Sato, E. Protein kinase B (PKB/Akt) is required for the completion of meiosis in mouse oocytes. Dev. Biol. 2008, 314, 215–223. [Google Scholar] [CrossRef] [Green Version]
  49. Andersen, C.B.; Roth, R.A.; Conti, M. Protein Kinase B/Akt Induces Resumption of Meiosis in Xenopus Oocytes. J. Biol. Chem. 1998, 273, 18705–18708. [Google Scholar] [CrossRef] [Green Version]
  50. Cecconi, S.; Rossi, G.; Santilli, A.; Di Stefano, L.; Hoshino, Y.; Sato, E.; Palmerini, M.G.; Macchiarelli, G. Akt expression in mouse oocytes matured in vivo and in vitro. Reprod. Biomed. Online 2010, 20, 35–41. [Google Scholar] [CrossRef] [Green Version]
  51. Procházka, R.; Bartková, A.; Němcová, L.; Murín, M.; Gad, A.; Marcollová, K.; Kinterová, V.; Lucas-Hahn, A.; Laurinčík, J. The Role of MAPK3/1 and AKT in the Acquisition of High Meiotic and Developmental Competence of Porcine Oocytes Cultured In Vitro in FLI Medium. Int. J. Mol. Sci. 2021, 22, 11148. [Google Scholar] [CrossRef]
  52. Das, D.; Khan, P.P.; Maitra, S. Participation of PI3-kinase/Akt signalling in insulin stimulation of p34cdc2 activation in zebrafish oocyte: Phosphodiesterase 3 as a potential downstream target. Mol. Cell. Endocrinol. 2013, 374, 46–55. [Google Scholar] [CrossRef]
  53. Schuh, M.; Ellenberg, J. Self-Organization of MTOCs Replaces Centrosome Function during Acentrosomal Spindle Assembly in Live Mouse Oocytes. Cell 2007, 130, 484–498. [Google Scholar] [CrossRef] [Green Version]
  54. Wu, T.; Dong, J.; Fu, J.; Kuang, Y.; Chen, B.; Gu, H.; Luo, Y.; Gu, R.; Zhang, M.; Li, W.; et al. The mechanism of acentrosomal spindle assembly in human oocytes. Science 2022, 378, eabq7361. [Google Scholar] [CrossRef]
  55. Clift, D.; Schuh, M. Restarting life: Fertilization and the transition from meiosis to mitosis. Nat. Rev. Mol. Cell Biol. 2013, 14, 549–562. [Google Scholar] [CrossRef]
  56. Gruss, O. Animal Female Meiosis: The Challenges of Eliminating Centrosomes. Cells 2018, 7, 73. [Google Scholar] [CrossRef] [Green Version]
  57. Tsuruta, F.; Masuyama, N.; Gotoh, Y. The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to Mitochondria. J. Biol. Chem. 2002, 277, 14040–14047. [Google Scholar] [CrossRef] [Green Version]
  58. Jiao, Y.; Li, J.; Zhu, S.; Ahmed, J.Z.; Li, M.; Shi, D.; Huang, B. PI3K inhibitor reduces in vitro maturation and developmental competence of porcine oocytes. Theriogenology 2020, 157, 432–439. [Google Scholar] [CrossRef]
  59. De Felici, M.; Klinger, F.G. PI3K/PTEN/AKT Signaling Pathways in Germ Cell Development and Their Involvement in Germ Cell Tumors and Ovarian Dysfunctions. Int. J. Mol. Sci. 2021, 22, 9838. [Google Scholar] [CrossRef]
  60. Li, X.; Chen, H.; Zhang, Z.; Xu, D.; Duan, J.; Li, X.; Yang, L.; Hua, R.; Cheng, J.; Li, Q. Isorhamnetin Promotes Estrogen Biosynthesis and Proliferation in Porcine Granulosa Cells via the PI3K/Akt Signaling Pathway. J. Agric. Food Chem. 2021, 69, 6535–6542. [Google Scholar] [CrossRef]
  61. Makker, A.; Goel, M.M.; Mahdi, A.A. PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: An update. J. Mol. Endocrinol. 2014, 53, R103–R118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Alberico, H.C.; Woods, D.C. Role of Granulosa Cells in the Aging Ovarian Landscape: A Focus on Mitochondrial and Metabolic Function. Front. Physiol. 2022, 12, 2566. [Google Scholar] [CrossRef] [PubMed]
  63. Huang, Z.; Wells, D. The human oocyte and cumulus cells relationship: New insights from the cumulus cell transcriptome. MHR Basic Sci. Reprod. Med. 2010, 16, 715–725. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Goto, M.; Iwase, A.; Ando, H.; Kurotsuchi, S.; Harata, T.; Kikkawa, F. PTEN and Akt expression during growth of human ovarian follicles. J. Assist. Reprod. Genet. 2007, 24, 541–546. [Google Scholar] [CrossRef] [Green Version]
  65. Brown, C.; LaRocca, J.; Pietruska, J.; Ota, M.; Anderson, L.; Duncan Smith, S.; Weston, P.; Rasoulpour, T.; Hixon, M.L. Subfertility Caused by Altered Follicular Development and Oocyte Growth in Female Mice Lacking PKBalpha/Akt11. Biol. Reprod. 2010, 82, 246–256. [Google Scholar] [CrossRef] [Green Version]
  66. Bezerra, M.É.S.; Barberino, R.S.; Menezes, V.G.; Gouveia, B.B.; Macedo, T.J.S.; Santos, J.M.S.; Monte, A.P.O.; Barros, V.R.P.; Matos, M.H.T. Insulin-like growth factor-1 (IGF-1) promotes primordial follicle growth and reduces DNA fragmentation through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signalling pathway. Reprod. Fertil. Dev. 2018, 30, 1503. [Google Scholar] [CrossRef]
  67. Alam, M.H.; Miyano, T. Interaction between growing oocytes and granulosa cells in vitro. Reprod. Med. Biol. 2020, 19, 13–23. [Google Scholar] [CrossRef] [Green Version]
  68. Alam, H.; Maizels, E.T.; Park, Y.; Ghaey, S.; Feiger, Z.J.; Chandel, N.S.; Hunzicker-Dunn, M. Follicle-stimulating Hormone Activation of Hypoxia-inducible Factor-1 by the Phosphatidylinositol 3-Kinase/AKT/Ras Homolog Enriched in Brain (Rheb)/Mammalian Target of Rapamycin (mTOR) Pathway Is Necessary for Induction of Select Protein Markers of Follic. J. Biol. Chem. 2004, 279, 19431–19440. [Google Scholar] [CrossRef] [Green Version]
  69. Zeleznik, A.J.; Saxena, D.; Little-Ihrig, L. Protein Kinase B Is Obligatory for Follicle-Stimulating Hormone-Induced Granulosa Cell Differentiation. Endocrinology 2003, 144, 3985–3994. [Google Scholar] [CrossRef] [Green Version]
  70. Bencomo, E.; Pérez, R.; Arteaga, M.-F.; Acosta, E.; Peña, O.; Lopez, L.; Avila, J.; Palumbo, A. Apoptosis of cultured granulosa-lutein cells is reduced by insulin-like growth factor I and may correlate with embryo fragmentation and pregnancy rate. Fertil. Steril. 2006, 85, 474–480. [Google Scholar] [CrossRef]
  71. Quirk, S.M.; Cowan, R.G.; Harman, R.M.; Hu, C.-L.; Porter, D.A. Ovarian follicular growth and atresia: The relationship between cell proliferation and survival. J. Anim. Sci. 2004, 82 (Suppl. 13), E40–E52. [Google Scholar] [CrossRef]
  72. Hu, C.-L.; Cowan, R.G.; Harman, R.M.; Quirk, S.M. Cell Cycle Progression and Activation of Akt Kinase Are Required for Insulin-Like Growth Factor I-Mediated Suppression of Apoptosis in Granulosa Cells. Mol. Endocrinol. 2004, 18, 326–338. [Google Scholar] [CrossRef] [Green Version]
  73. Johnson, A.L.; Bridgham, J.T.; Swenson, J.A. Activation of the Akt/Protein Kinase B Signaling Pathway Is Associated with Granulosa Cell Survival1. Biol. Reprod. 2001, 64, 1566–1574. [Google Scholar] [CrossRef] [Green Version]
  74. Demiray, S.B.; Goker, E.N.T.; Tavmergen, E.; Yilmaz, O.; Calimlioglu, N.; Soykam, H.O.; Oktem, G.; Sezerman, U. Differential gene expression analysis of human cumulus cells. Clin. Exp. Reprod. Med. 2019, 46, 76–86. [Google Scholar] [CrossRef] [Green Version]
  75. Turathum, B.; Gao, E.-M.; Chian, R.-C. The Function of Cumulus Cells in Oocyte Growth and Maturation and in Subsequent Ovulation and Fertilization. Cells 2021, 10, 2292. [Google Scholar] [CrossRef]
  76. Shimada, M.; Ito, J.; Yamashita, Y.; Okazaki, T.; Isobe, N. Phosphatidylinositol 3-kinase in cumulus cells is responsible for both suppression of spontaneous maturation and induction of gonadotropin-stimulated maturation of porcine oocytes. J. Endocrinol. 2003, 179, 25–34. [Google Scholar] [CrossRef] [Green Version]
  77. Coticchio, G.; Sereni, E.; Serrao, L.; Mazzone, S.; Iadarola, I.; Borini, A. What criteria for the definition of oocyte quality? Ann. N. Y. Acad. Sci. 2004, 1034, 132–144. [Google Scholar] [CrossRef]
  78. Artini, P.G.; Tatone, C.; Sperduti, S.; D’Aurora, M.; Franchi, S.; Di Emidio, G.; Ciriminna, R.; Vento, M.; Di Pietro, C.; Stuppia, L.; et al. Cumulus cells surrounding oocytes with high developmental competence exhibit down-regulation of phosphoinositol 1,3 kinase/protein kinase B (PI3K/AKT) signalling genes involved in proliferation and survival. Hum. Reprod. 2017, 32, 2474–2484. [Google Scholar] [CrossRef]
  79. Haghighat, N.; Van Winkle, L.J. Developmental change in follicular cell-enhanced amino acid uptake into mouse oocytes that depends on intact gap junctions and transport system gly. J. Exp. Zool. 1990, 253, 71–82. [Google Scholar] [CrossRef]
  80. El-Hayek, S.; Yang, Q.; Abbassi, L.; FitzHarris, G.; Clarke, H.J. Mammalian Oocytes Locally Remodel Follicular Architecture to Provide the Foundation for Germline-Soma Communication. Curr. Biol. 2018, 28, 1124–1131.e3. [Google Scholar] [CrossRef] [Green Version]
  81. Baena, V.; Terasaki, M. Three-dimensional organization of transzonal projections and other cytoplasmic extensions in the mouse ovarian follicle. Sci. Rep. 2019, 9, 1262. [Google Scholar] [CrossRef] [PubMed]
  82. Perkins, G.; Goodenough, D.; Sosinsky, G. Three-Dimensional Structure of the Gap Junction Connexon. Biophys. J. 1997, 72, 533–544. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Fang, Y.; Shang, W.; Wei, D.-L.; Zeng, S.-M. Cited2 protein level in cumulus cells is a biomarker for human embryo quality and pregnancy outcome in one in vitro fertilization cycle. Fertil. Steril. 2016, 105, 1351–1359.e4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Gatta, V.; Tatone, C.; Ciriminna, R.; Vento, M.; Franchi, S.; D’Aurora, M.; Sperduti, S.; Cela, V.; Borzì, P.; Palermo, R.; et al. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulatin. Fertil. Steril. 2013, 99, 2000–2008.e1. [Google Scholar] [CrossRef] [PubMed]
  85. Winterhager, E.; Kidder, G.M. Gap junction connexins in female reproductive organs: Implications for women’s reproductive health. Hum. Reprod. Updat. 2015, 21, 340–352. [Google Scholar] [CrossRef] [Green Version]
  86. Dunn, C.A.; Lampe, P.D. Injury-triggered Akt phosphorylation of Cx43: A ZO-1-driven molecular switch that regulates gap junction size. J. Cell Sci. 2013, 127, 455–464. [Google Scholar] [CrossRef] [Green Version]
  87. Shimada, M.; Terada, T. Phosphorylation of Connexin-43, Gap Junctional Protein, in Cumulus Cells is Regulated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase during In Vitro Meiotic Resumption in Porcine Follicular Oocytes. J. Mamm. Ova Res. 1999, 16, 37–42. [Google Scholar] [CrossRef] [Green Version]
  88. Shimada, M.; Terada, T. Phosphatidylinositol 3-kinase in cumulus cells and oocytes is responsible for activation of oocyte mitogen-activated protein kinase during meiotic progression beyond the meiosis I stage in pigs. Biol. Reprod. 2001, 64, 1106–1114. [Google Scholar] [CrossRef] [Green Version]
  89. Camaioni, A.; Salustri, A.; Yanagishita, M.; Hascall, V.C. Proteoglycans and Proteins in the Extracellular Matrix of Mouse Cumulus Cell–Oocyte Complexes. Arch. Biochem. Biophys. 1996, 325, 190–198. [Google Scholar] [CrossRef]
  90. Nagyova, E.; Scsukova, S.; Kalous, J.; Mlynarcikova, A. Effects of RU486 and indomethacin on meiotic maturation, formation of extracellular matrix, and progesterone production by porcine oocyte-cumulus complexes. Domest. Anim. Endocrinol. 2014, 48, 7–14. [Google Scholar] [CrossRef]
  91. Nagyova, E.; Kalous, J.; Nemcova, L. Increased expression of pentraxin 3 after in vivo and in vitro stimulation with gonadotropins in porcine oocyte-cumulus complexes and granulosa cells. Domest. Anim. Endocrinol. 2016, 56, 29–35. [Google Scholar] [CrossRef]
  92. Němcová, L.; Nagyová, E.; Petlach, M.; Tománek, M.; Procházka, R. Molecular Mechanisms of Insulin-Like Growth Factor 1 Promoted Synthesis and Retention of Hyaluronic Acid in Porcine Oocyte-Cumulus Complexes1. Biol. Reprod. 2007, 76, 1016–1024. [Google Scholar] [CrossRef] [Green Version]
  93. Procházka, R.; Petlach, M.; Nagyová, E.; Němcová, L. Effect of epidermal growth factor-like peptides on pig cumulus cell expansion, oocyte maturation, and acquisition of developmental competence in vitro: Comparison with gonadotropins. Reproduction 2011, 141, 425–435. [Google Scholar] [CrossRef] [Green Version]
  94. Blaha, M.; Prochazka, R.; Adamkova, K.; Nevoral, J.; Nemcova, L. Prostaglandin E2 stimulates the expression of cumulus expansion-related genes in pigs: The role of protein kinase B. Prostaglandins Other Lipid Mediat. 2017, 130, 38–46. [Google Scholar] [CrossRef]
  95. Guo, J.; Shi, L.; Gong, X.; Jiang, M.; Yin, Y.; Zhang, X.; Yin, H.; Li, H.; Emori, C.; Sugiura, K.; et al. Oocyte-dependent activation of MTOR in cumulus cells controls the development and survival of cumulus-oocyte complexes. J. Cell Sci. 2016, 129, 3091–3103. [Google Scholar] [CrossRef] [Green Version]
  96. Sarbassov, D.D.; Guertin, D.A.; Ali, S.M.; Sabatini, D.M. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex. Science 2005, 307, 1098–1101. [Google Scholar] [CrossRef] [Green Version]
  97. Jacinto, E.; Loewith, R.; Schmidt, A.; Lin, S.; Rüegg, M.A.; Hall, A.; Hall, M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 2004, 6, 1122–1128. [Google Scholar] [CrossRef]
  98. Starkman, B.G.; Cravero, J.D.; Delcarlo, M.; Loeser, R.F. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem. J. 2005, 389, 723–729. [Google Scholar] [CrossRef] [Green Version]
  99. Varma, S.; Shrivastav, A.; Changela, S.; Khandelwal, R.L. Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity. Exp. Cell Res. 2008, 314, 1281–1291. [Google Scholar] [CrossRef]
  100. Kapp, L.D.; Lorsch, J.R. The Molecular Mechanics of Eukaryotic Translation. Annu. Rev. Biochem. 2004, 73, 657–704. [Google Scholar] [CrossRef]
  101. Dowling, R.J.O.; Topisirovic, I.; Fonseca, B.D.; Sonenberg, N. Dissecting the role of mTOR: Lessons from mTOR inhibitors. Biochim. Biophys. Acta-Proteins Proteom. 2010, 1804, 433–439. [Google Scholar] [CrossRef]
  102. Nitta, N.; Nakasu, S.; Shima, A.; Nozaki, K. mTORC1 signaling in primary central nervous system lymphoma. Surg. Neurol. Int. 2016, 7, 475. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Schmelzle, T.; Hall, M.N. TOR, a Central Controller of Cell Growth. Cell 2000, 103, 253–262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Gingras, A.-C.; Kennedy, S.G.; O’Leary, M.A.; Sonenberg, N.; Hay, N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 1998, 12, 502–513. [Google Scholar] [CrossRef]
  105. Ma, X.M.; Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 2009, 10, 307–318. [Google Scholar] [CrossRef] [PubMed]
  106. Hsieh, A.C.; Ruggero, D. Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer. Clin. Cancer Res. 2010, 16, 4914–4920. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Kovacina, K.S.; Park, G.Y.; Bae, S.S.; Guzzetta, A.W.; Schaefer, E.; Birnbaum, M.J.; Roth, R.A. Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding Partner. J. Biol. Chem. 2003, 278, 10189–10194. [Google Scholar] [CrossRef] [Green Version]
  108. Wang, L.; Harris, T.E.; Roth, R.A.; Lawrence, J.C. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding. J. Biol. Chem. 2007, 282, 20036–20044. [Google Scholar] [CrossRef] [Green Version]
  109. Manning, B.D.; Cantley, L.C. United at last: The tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem. Soc. Trans. 2003, 31, 573–578. [Google Scholar] [CrossRef]
  110. Inoki, K.; Li, Y.; Zhu, T.; Wu, J.; Guan, K.-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 2002, 4, 648–657. [Google Scholar] [CrossRef]
  111. Tee, A.R.; Manning, B.D.; Roux, P.P.; Cantley, L.C.; Blenis, J. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb. Curr. Biol. 2003, 13, 1259–1268. [Google Scholar] [CrossRef] [Green Version]
  112. Cohen, P.; Frame, S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001, 2, 769–776. [Google Scholar] [CrossRef]
  113. Wang, X. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase. EMBO J. 2001, 20, 4370–4379. [Google Scholar] [CrossRef]
  114. Guo, J.; Zhang, T.; Guo, Y.; Sun, T.; Li, H.; Zhang, X.; Yin, H.; Cao, G.; Yin, Y.; Wang, H.; et al. Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice. Proc. Natl. Acad. Sci. USA 2018, 115, E5326–E5333. [Google Scholar] [CrossRef] [Green Version]
  115. Susor, A.; Jansova, D.; Cerna, R.; Danylevska, A.; Anger, M.; Toralova, T.; Malik, R.; Supolikova, J.; Cook, M.S.; Oh, J.S.; et al. Temporal and spatial regulation of translation in the mammalian oocyte via the mTOR–eIF4F pathway. Nat. Commun. 2015, 6, 6078. [Google Scholar] [CrossRef] [Green Version]
  116. Šušor, A.; Jelínková, L.; Karabínová, P.; Torner, H.; Tomek, W.; Kovářová, H.; Kubelka, M. Regulation of cap-dependent translation initiation in the early stage porcine parthenotes. Mol. Reprod. Dev. 2008, 75, 1716–1725. [Google Scholar] [CrossRef]
  117. Kogasaka, Y.; Hoshino, Y.; Hiradate, Y.; Tanemura, K.; Sato, E. Distribution and association of mTOR with its cofactors, raptor and rictor, in cumulus cells and oocytes during meiotic maturation in mice. Mol. Reprod. Dev. 2013, 80, 334–348. [Google Scholar] [CrossRef]
  118. Jansova, D.; Koncicka, M.; Tetkova, A.; Cerna, R.; Malik, R.; del Llano, E.; Kubelka, M.; Susor, A. Regulation of 4E-BP1 activity in the mammalian oocyte. Cell Cycle 2017, 16, 927–939. [Google Scholar] [CrossRef] [Green Version]
  119. El Sheikh, M.; Mesalam, A.; Mesalam, A.A.; Idrees, M.; Lee, K.-L.; Kong, I.-K. Melatonin Abrogates the Anti-Developmental Effect of the AKT Inhibitor SH6 in Bovine Oocytes and Embryos. Int. J. Mol. Sci. 2019, 20, 2956. [Google Scholar] [CrossRef] [Green Version]
  120. Li, Y.; Chandrakanthan, V.; Day, M.L.; O’Neill, C. Direct Evidence for the Action of Phosphatidylinositol (3,4,5)-Trisphosphate-Mediated Signal Transduction in the 2-Cell Mouse Embryo1. Biol. Reprod. 2007, 77, 813–821. [Google Scholar] [CrossRef] [Green Version]
  121. Jin, X.L.; Chandrakanthan, V.; Morgan, H.D.; O’Neill, C. Preimplantation Embryo Development in the Mouse Requires the Latency of TRP53 Expression, Which Is Induced by a Ligand-Activated PI3 Kinase/AKT/MDM2-Mediated Signaling Pathway1. Biol. Reprod. 2009, 80, 286–294. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Li, Y.; Tang, J.; Ji, X.; Hua, M.-M.; Liu, M.; Chang, L.; Gu, Y.; Shi, C.; Ni, W.; Liu, J.; et al. Regulation of the mammalian maternal-to-embryonic transition by eukaryotic translation initiation factor 4E. Development 2021, 148, dev190793. [Google Scholar] [CrossRef] [PubMed]
  123. Bahrami, M.; Morris, M.B.; Day, M.L. Amino acid supplementation of a simple inorganic salt solution supports efficient in vitro maturation (IVM) of bovine oocytes. Sci. Rep. 2019, 9, 11739. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Summers, M.C.; Biggers, J.D. Chemically defined media and the culture of mammalian preimplantation embryos: Historical perspective and current issues. Hum. Reprod. Updat. 2003, 9, 557–582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  125. Zamfirescu, R.C.; Day, M.L.; Morris, M.B. mTORC1/2 signaling is downregulated by amino acid-free culture of mouse preimplantation embryos and is only partially restored by amino acid readdition. Am. J. Physiol. Cell Physiol. 2021, 320, C30–C44. [Google Scholar] [CrossRef]
  126. Song, B.-S.; Jeong, P.-S.; Lee, J.-H.; Lee, M.-H.; Yang, H.-J.; Choi, S.-A.; Lee, H.-Y.; Yoon, S.-B.; Park, Y.-H.; Jeong, K.-J.; et al. The effects of kinase modulation on in vitro maturation according to different cumulus-oocyte complex morphologies. PLoS ONE 2018, 13, e0205495. [Google Scholar] [CrossRef] [Green Version]
  127. Baran, V.; Fabian, D.; Rehak, P. Akt/PKB plays role of apoptosis relay on entry into first mitosis of mouse embryo. Zygote 2013, 21, 406–416. [Google Scholar] [CrossRef]
  128. Fiorenza, M.T.; Torcia, S.; Canterini, S.; Bevilacqua, A.; Narducci, M.G.; Ragone, G.; Croce, C.M.; Russo, G.; Mangia, F. TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos. Cell Death Differ. 2008, 15, 420–422. [Google Scholar] [CrossRef] [Green Version]
  129. Fiorenza, M.T.; Russo, G.; Narducci, M.G.; Bresin, A.; Mangia, F.; Bevilacqua, A. Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. J. Cell. Physiol. 2020, 235, 3393–3401. [Google Scholar] [CrossRef] [Green Version]
  130. Chen, J.; Lian, X.; Du, J.; Xu, S.; Wei, J.; Pang, L.; Song, C.; He, L.; Wang, S. Inhibition of phosphorylated Ser473-Akt from translocating into the nucleus contributes to 2-cell arrest and defective zygotic genome activation in mouse preimplantation embryogenesis. Dev. Growth Differ. 2016, 58, 280–292. [Google Scholar] [CrossRef] [Green Version]
  131. Ashry, M.; Rajput, S.K.; Folger, J.K.; Knott, J.G.; Hemeida, N.A.; Kandil, O.M.; Ragab, R.S.; Smith, G.W. Functional role of AKT signaling in bovine early embryonic development: Potential link to embryotrophic actions of follistatin. Reprod. Biol. Endocrinol. 2018, 16, 1. [Google Scholar] [CrossRef] [Green Version]
  132. Riley, J.K.; Carayannopoulos, M.O.; Wyman, A.H.; Chi, M.; Ratajczak, C.K.; Moley, K.H. The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo. Dev. Biol. 2005, 284, 377–386. [Google Scholar] [CrossRef] [Green Version]
  133. Buttrick, G.J.; Beaumont, L.M.A.; Leitch, J.; Yau, C.; Hughes, J.R.; Wakefield, J.G. Akt regulates centrosome migration and spindle orientation in the early Drosophila melanogaster embryo. J. Cell Biol. 2008, 180, 537–548. [Google Scholar] [CrossRef] [Green Version]
  134. Xu, S.; Pang, L.; Liu, Y.; Lian, X.; Mo, K.; Lv, R.; Zhu, H.; Lv, C.; Lin, J.; Sun, J.; et al. Akt plays indispensable roles during the first cell lineage differentiation of mouse. J. Mol. Histol. 2019, 50, 369–374. [Google Scholar] [CrossRef]
Cells 12 01830 g001 550
Figure 1. Akt and maturation-promoting factor (MPF) activity during meiotic maturation, oocyte-to-embryo transition and early embryo development. During the first meiotic arrest at the germinal vesicle (GV) stage, Akt is inactivated. During germinal vesicle breakdown (GVBD), MPF and Akt activity increases. At meiosis I (MI) stage, Akt activity is remains stable and activity of MPF reaches maximum. At the MI/meiosis II (MII) transition, cyclin B is destructed by the anaphase promoting complex/cyclosome (APC/C), MPF activity is reduced, and the first polar body is extruded. The second metaphase plate is formed at the MII stage, and meiosis is stopped in the second meiotic arrest. Akt activity is maintained after the first polar body extrusion, MPF activity is restored to the MI levels, and the oocyte awaits fertilization. After fertilization, MPF activity is downregulated, Akt activity persists in the zygote, when the second polar body is extruded, and both male and female pronuclei are formed. MPF activity is restored before the first mitotic division. At the 2-cell embryonic stage, the first mitotic division is completed, Akt remains activated and MPF activity declines. Akt is involved in the regulation of zygotic genome activation (ZGA) which occurs in mouse embryo at the 2-cell stage. During the early embryo development, the Akt activity remains at high levels and MPF activity is cyclically downregulated and restored at each subsequent mitotic division.
Figure 1. Akt and maturation-promoting factor (MPF) activity during meiotic maturation, oocyte-to-embryo transition and early embryo development. During the first meiotic arrest at the germinal vesicle (GV) stage, Akt is inactivated. During germinal vesicle breakdown (GVBD), MPF and Akt activity increases. At meiosis I (MI) stage, Akt activity is remains stable and activity of MPF reaches maximum. At the MI/meiosis II (MII) transition, cyclin B is destructed by the anaphase promoting complex/cyclosome (APC/C), MPF activity is reduced, and the first polar body is extruded. The second metaphase plate is formed at the MII stage, and meiosis is stopped in the second meiotic arrest. Akt activity is maintained after the first polar body extrusion, MPF activity is restored to the MI levels, and the oocyte awaits fertilization. After fertilization, MPF activity is downregulated, Akt activity persists in the zygote, when the second polar body is extruded, and both male and female pronuclei are formed. MPF activity is restored before the first mitotic division. At the 2-cell embryonic stage, the first mitotic division is completed, Akt remains activated and MPF activity declines. Akt is involved in the regulation of zygotic genome activation (ZGA) which occurs in mouse embryo at the 2-cell stage. During the early embryo development, the Akt activity remains at high levels and MPF activity is cyclically downregulated and restored at each subsequent mitotic division.
Cells 12 01830 g001
Cells 12 01830 g002 550
Figure 2. Akt regulates mRNA translation. Akt directly activates mammalian target of rapamycin complex 1 (mTORC1) by phosphorylating and inactivating proline-rich Akt substrate 40 kDa (PRAS40), a protein that is associated with mTORC1. Further, Akt also activates mTORC1 indirectly by phosphorylating and inactivating the tuberous sclerosis complex 1 (TSC1) and tuberous sclerosis complex 2 (TCS2). TSC1/TSC2 functional complex acts as a key upstream negative regulator of mTORC1 activity. TSC2 has a role as a GTPase-activating protein (GAP) which inactivates an essential mTORC1 activator, the RAS homologue enriched in brain (Rheb). MTORC1 phosphorylates and activates the 70-kDa ribosomal protein S6 kinase (p70S6K), which phosphorylates the eukaryotic translation initiation factor 4B (eIF4B). The eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1), phosphorylated and activated by mTORC1, is released from eIF4E and the assembly of the eIF4F complex is enabled. Factors involved in cap-dependent translation initiation are depicted in green, the upstream factors in red. Stimulatory modification is depicted as an arrow, inhibitory modification as a blunt end line.
Figure 2. Akt regulates mRNA translation. Akt directly activates mammalian target of rapamycin complex 1 (mTORC1) by phosphorylating and inactivating proline-rich Akt substrate 40 kDa (PRAS40), a protein that is associated with mTORC1. Further, Akt also activates mTORC1 indirectly by phosphorylating and inactivating the tuberous sclerosis complex 1 (TSC1) and tuberous sclerosis complex 2 (TCS2). TSC1/TSC2 functional complex acts as a key upstream negative regulator of mTORC1 activity. TSC2 has a role as a GTPase-activating protein (GAP) which inactivates an essential mTORC1 activator, the RAS homologue enriched in brain (Rheb). MTORC1 phosphorylates and activates the 70-kDa ribosomal protein S6 kinase (p70S6K), which phosphorylates the eukaryotic translation initiation factor 4B (eIF4B). The eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1), phosphorylated and activated by mTORC1, is released from eIF4E and the assembly of the eIF4F complex is enabled. Factors involved in cap-dependent translation initiation are depicted in green, the upstream factors in red. Stimulatory modification is depicted as an arrow, inhibitory modification as a blunt end line.
Cells 12 01830 g002
Cells 12 01830 g003 550
Figure 3. Co-localization of Akt with 4E/BP1 and mTORC1/mTORC2 at the meiosis I (MI) and meiosis II (MII) spindles. The p473-Akt and mTORC1 are distributed along microtubules, the p308-Akt and mTORC2 are localized at spindle poles where microtubule-organizing centers (MTOCs) are positioned. 4E-BP1 is detected along microtubules and at spindle poles.
Figure 3. Co-localization of Akt with 4E/BP1 and mTORC1/mTORC2 at the meiosis I (MI) and meiosis II (MII) spindles. The p473-Akt and mTORC1 are distributed along microtubules, the p308-Akt and mTORC2 are localized at spindle poles where microtubule-organizing centers (MTOCs) are positioned. 4E-BP1 is detected along microtubules and at spindle poles.
Cells 12 01830 g003
Table
Table 1. Role of Akt in regulation of mitosis.
Table 1. Role of Akt in regulation of mitosis.
Cell Cycle StageAkt Role in MitosisReferences
G1 phaseAkt/mTOR stimulates expression of cyclin D1, CDK4 and CDC25A, that are involved in cell growth and proliferation[26]
G1/SAkt promotes inactivation of p21WAF1 and p27kip1, the CDK2 inhibitors[27,28]
S/G2Enhanced Akt activity indicates a role for Akt in the S/G2 transition [29]
G2/MAkt regulates cell cycle progression by direct phosphorylation and inactivation of Wee1 and Myt1 kinases and activates the CDC25 phosphatase [23,24,25]
M-phaseAkt is involved in the control of the mitotic spindle checkpoint affects the integrity and composition of mitotic centrosomes[30,31]
CytokinesisAkt participates in the regulation of cytokinesis[32]
Table
Table 2. Role of Akt in meiosis progression.
Table 2. Role of Akt in meiosis progression.
Meiosis StageAkt Role in MeiosisReferences
Prophase of 1st meiosisAkt is involved in CDK1 activation and GVBD induction during meiosis resumption [42,43,44,45,46]
MI/MII transitionAkt is required for the transition from meiotic metaphase I (MI) to metaphase II (MII)[39,43,47,48,49]
MI and MII-phaseAkt participates in the formation and stabilization of the MI and MII meiotic spindles [43,48,50]
MI and MII-phase Akt contributes to centrosome integrity in oocytes[43]
Meiosis completionAkt is necessary for completion of meiosis[47,48,51]
Table
Table 3. Role of Akt in the early embryo development.
Table 3. Role of Akt in the early embryo development.
Stage of Early EmbryoRole of Akt in the Early Embryo DevelopmentReferences
1-cellAkt is essential for the entry of 1-cell mouse embryos into the first mitosis[127,128]
2-cell, ZGApSer473-Akt is localized to the nuclei of 2-cell embryos, Akt is possibly involved in the major ZGA of 2-cell mouse embryos[129,130]
8- to 16-cellAkt is important for mouse embryo development to the 8- to 16-cells[131]
BlastocystAkt is necessary for embryo development to the blastocyst stage[120,126,128,131,132]
Early embryoIn the early Drosophila melanogaster embryo, Akt regulates centrosome migration, promotes mitotic spindle orientation and proper spindle morphology[133]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kalous, J.; Aleshkina, D.; Anger, M. A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development. Cells 2023, 12, 1830. https://doi.org/10.3390/cells12141830

AMA Style

Kalous J, Aleshkina D, Anger M. A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development. Cells. 2023; 12(14):1830. https://doi.org/10.3390/cells12141830

Chicago/Turabian Style

Kalous, Jaroslav, Daria Aleshkina, and Martin Anger. 2023. "A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development" Cells 12, no. 14: 1830. https://doi.org/10.3390/cells12141830

APA Style

Kalous, J., Aleshkina, D., & Anger, M. (2023). A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development. Cells, 12(14), 1830. https://doi.org/10.3390/cells12141830

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop